July 23, 2021
In this letter, ACHP provides recommendations to the Biden Administration on how to improve the Requirements Related to Prescription Drug Reporting executive order. ACHP calls for explore reporting requirements for drug makers and streamlining the reporting process on pharmacy benefits.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.
